Histological Features of Kaposi Sarcoma in a Patient Receiving Highly Active Antiviral Therapy

American Journal of Dermatopathology

Volumn 26, Issue 2, 2004, Pages 127-132

  Eng, William ^a   Cockerell, Clay J ^b,c  

^a LABORATORY CORPORATION OF AMERICA   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c NONE   (United States)

Author keywords

AIDS; Human herpesvirus 8; Human immunodeficiency virus; Reconstitution syndrome

Indexed keywords

ACICLOVIR; AZITHROMYCIN; FLUCONAZOLE; LAMIVUDINE; NELFINAVIR; RECOMBINANT ERYTHROPOIETIN; STAVUDINE; TEMAZEPAM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 1842614389     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200404000-00008     Document Type: Article

References (12)

1. Pezzotti P, Serraino D, Rezza G, et al. The spectrum of AIDS-defining diseases. Int J Epidemiol. 1999;28:975-981.
2. Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet. 1998;351:252-255.
3. Conant MA, Opp KM, Poretz D, et al. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir (letter). AIDS. 1997;11:1300-1301.
4. Murphy M, Armstrong D, Sepkowitz KA, et al. Regression of AIDS-related Kaposi's sarcoma following treatment with HIV-1 protease inhibitor (letter). AIDS. 1997;11:261-262.
5. Cattelan AM, Calabro ML, Aversa SML, et al. Regression of AIDS-related Kaposi's sarcoma following anti-retroviral therapy with protease inhibitors: Biological correlates of clinical outcome. Eur J Cancer. 1999;35:1809-1815.
6. Blum L, Pellet C, Agbalika F, et al. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus 8 sequences during anti-HIV protease therapy (letter). AIDS. 1997;11:1653-1655.
7. Burdick AE, Carmichael C, Rady PL, et al. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitors therapy (letter). J Am Acad Dermatol. 1997;37:648-649.
8. Vaccher E, Di Gennaro G, Nasti G, et al. HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy. J AIDS. 1999;22:407-408.
9. Hardy MA, Goldfarb P, Levine S, et al. De novo Kaposi's sarcoma in renal transplantation. Case report and brief review. Cancer. 1976;38:144-148.
10. Kostianovsky M, Lamy Y, Greco MA. Immunohistochemical and electron microscopic profiles of cutaneous Kaposi's sarcoma and bacillary angiomatosis. Ultrastruct Pathol. 1992;16:629-640.
11. Kempf W, Adams V, Wey N, et al. CD68+ cells of monocyte/macrophage linage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc Natl Acad Sci U S A. 1997;94:7600-7605.
12. Hsiao CH, Su IJ, Hsieh SW, et al. Epstein-Bar virus-associated intravascular lymphomatosis within Kaposi's sarcoma in an AIDS patient. Am J Surg Pathol. 1999;23:482-487.